Release Date: 24/08/22 08:16 Summary: BLY Announces First Half 2022 Results Price Sensitive: Yes Download Document 344.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%